Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07743164 |
| Title | A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) |
| Acronym | MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05 |
| Recruitment | Recruiting |
| Gender | female |
| Phase | Phase III |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | ISR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| MemorialCare Orange Coast Medical Center ( Site 0032) | RECRUITING | Fountain Valley | California | 92708 | United States | Details |
| Orlando Health Cancer Institute ( Site 0018) | RECRUITING | Orlando | Florida | 32806 | United States | Details |
| Sourasky Medical Center ( Site 2701) | RECRUITING | Tel Aviv | 6423906 | Israel | Details | |
| National Cheng Kung University Hospital ( Site 5304) | RECRUITING | Tainan | 704302 | Taiwan | Details |